Database assessment of the effectiveness of brand versus generic rosiglitazone in patients with type 2 diabetes mellitus

Ronen Loebstein*, Itzhak Katzir, Janet Vasterman-Landes, Hillel Halkin, Yossef Lomnicky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Database assessment of the effectiveness of brand versus generic rosiglitazone in patients with type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences